EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human Enteroviruses

Xiaojing Lin, Qiang Sun, Yang Cao, Zi Li, Cuiling Xu, Jun Liu, Jingdong Song, Kun Qin, Yong Zhang, Jianfang Zhou iD

Biomolecules · 2024

DOI: 10.3390/biom14101331 ↗

At a glance

Journal article in Biomolecules, 2024. Written by Xiaojing Lin and 9 co-authors. Institution: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Pr…. Major MEDLINE topics: Antiviral Agents, Enterovirus D, Human, Peptides. Cited 4 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Enteroviruses have been a historical concern since the identification of polioviruses in humans. Wild polioviruses have almost been eliminated, while multiple species of non-polio enteroviruses and their variants co-circulate annually. To date, at least 116 types have been found in humans and are grouped into the species Enterovirus A–D and Rhinovirus A–C. However, there are few available antiviral drugs, especially with a universal pharmaceutical effect. Here, we demonstrate that peptide P25 from EV-D68 has broad antiviral activity against EV A–D enteroviruses in vitro. P25, derived from the HI loop and β-I sheet of VP1, operates through a conserved hydrophilic motif -R---K-K--K- and the hydrophobic F near the N-terminus. It could prevent viral infection of EV-A71 by competing for the heparan sulfate (HS) receptor, binding and stabilizing virions by suppressing the release of the viral genome. P25 also inhibited the generation of infectious viral particles by reducing viral protein synthesis. The molecular docking revealed that P25 might bind to the pocket opening area, a potential target for broad-spectrum antivirals. Our findings implicate the multiple antiviral effects of peptide P25, including blocking viral binding to the HS receptor, impeding viral genome release, and reducing progeny particles, which could be a novel universal anti-enterovirus drug candidate.

Subjects

MeSH terms (MEDLINE)

Antiviral AgentsEnterovirus D, HumanPeptidesHumansMolecular Docking SimulationCapsid ProteinsEnterovirusEnterovirus InfectionsVirus Replication

Author keywords

EV-D68antiviralbroad-spectrumhuman enterovirusespeptide

Substances

Antiviral AgentsPeptidesCapsid Proteins

Authors and institutions

  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 1…
  • Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment, Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610064, China.

ORCID profiles: Jianfang Zhou

Funding

  • National Key Research and Development Program of China

Cite

APA

Lin, X., Sun, Q., Cao, Y., Li, Z., Xu, C., Liu, J., Song, J., Qin, K., Zhang, Y., & Zhou, J. (2024). A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human Enteroviruses. Biomolecules. https://doi.org/10.3390/biom14101331

Vancouver

Lin X, Sun Q, Cao Y, Li Z, Xu C, Liu J, et al. A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human Enteroviruses. Biomolecules. 2024. doi:10.3390/biom14101331

BibTeX
@article{Lin2024,
  author = {Lin, Xiaojing and Sun, Qiang and Cao, Yang and Li, Zi and Xu, Cuiling and Liu, Jun and Song, Jingdong and Qin, Kun and Zhang, Yong and Zhou, Jianfang},
  title = {A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human Enteroviruses},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14101331}
}
Start for free →